Media Releases

The largest ever randomised controlled trial in IgA nephropathy has found that treatment with methylprednisolone - a cheap, widely used corticosteroid drug - halves the risk of losing kidney function and kidney failure, and that this can be effectively achieved with fewer side effects if a reduced dose is used.

Salt substitution has been shown to reduce stroke risk by 14 percent and the number of strokes and heart attacks combined by 13 percent, but this new analysis revealed that the costs saved as a result outweighed the cost of the intervention.

This first large high-quality clinical trial to assess the effects of traditional Chinese medicine in patients who have suffered a stroke has successfully completed the first stage of set-up, with 170 patients enrolled across 15 centres in China.